Comparative Pharmacology

Head-to-head clinical analysis: AMPICILLIN versus PENICILLIN VK.

Peer-Reviewed Evidence

Differential Analysis

Ampicillin vs PENICILLIN-VK

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

Ampicillin

Penicillin Antibiotic

Category A/B

PENICILLIN-VK

Penicillin Antibiotic

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Ampicillin is a penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and disrupting peptidoglycan cross-linking.

Penicillin VK inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.

Clinical Dosing

250-500 mg orally every 6 hours; 1-2 g IV/IM every 4-6 hours.

250-500 mg orally every 6-8 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections (e.g., streptococcal pharyngitis, skin infections).

Direct Interaction

None Documented

Half-Life

Terminal elimination half-life: 1-1.8 hours in adults with normal renal function; prolonged to 7-20 hours in end-stage renal disease (CrCl <10 mL/min).

Other Significant Interactions

Clinical Note

moderate

Ampicillin + Acemetacin

"Ampicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."

Clinical Note

moderate

Ampicillin + Probenecid

"The serum concentration of Probenecid can be increased when it is combined with Ampicillin."

Clinical Note

moderate

Bacampicillin + Probenecid

"The serum concentration of Probenecid can be increased when it is combined with Bacampicillin."

Clinical Note

moderate

Pivampicillin + Probenecid